Pınar, İbrahim E. and Ozkocaman, V. (2023) “Efficacy and safety outcomes of single-agent ibrutinib therapy in chronic lymphocytic leukemia and relapsed/refractory mantle-cell lymphoma”, The European Research Journal, 9(6), pp. 1483–1492. doi:10.18621/eurj.1359362.